Innovatus Capital Provides $26.2MM Refi for Exagen

Exagen amended its loan and security agreement with its primary lender, an affiliate of Innovatus Capital Partners to provide a $26.2 million, five-year term loan at 8.5% interest, of which 2.0% is paid in-kind in the form of additional term loans.

Innovatus Provides $23MM Term Loan to Biodesix

Innovatus Capital Partners provided a $23 million term loan in a debt refinancing agreement with Biodesix, a molecular diagnostics company that develops and commercializes non-invasive, blood-based diagnostic tests for oncology.